BRPI0514672A - polipeptìdeos de fusobacterium e métodos de uso - Google Patents

polipeptìdeos de fusobacterium e métodos de uso

Info

Publication number
BRPI0514672A
BRPI0514672A BRPI0514672-0A BRPI0514672A BRPI0514672A BR PI0514672 A BRPI0514672 A BR PI0514672A BR PI0514672 A BRPI0514672 A BR PI0514672A BR PI0514672 A BRPI0514672 A BR PI0514672A
Authority
BR
Brazil
Prior art keywords
methods
polypeptides
fusobacterium
fusobacterium polypeptides
present
Prior art date
Application number
BRPI0514672-0A
Other languages
English (en)
Inventor
Daryll A Emery
Darren E Straub
Original Assignee
Epitopix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitopix Llc filed Critical Epitopix Llc
Publication of BRPI0514672A publication Critical patent/BRPI0514672A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

POLIPEPTìDEOS DE FUSOBACTERIUM E MéTODOS DE USO A presente invenção fornece polipeptídeos isolados isoláveis a partir de Fusobacterium spp. Também são fornecidas pela presente invenção composições que incluem um ou mais dos polipeptídeos e métodos para fazê-las e métodos para usar os polipeptídeos.
BRPI0514672-0A 2004-08-25 2005-08-25 polipeptìdeos de fusobacterium e métodos de uso BRPI0514672A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60434904P 2004-08-25 2004-08-25
PCT/US2005/030290 WO2006026373A1 (en) 2004-08-25 2005-08-25 Fusobacterium polypeptides and methods of use

Publications (1)

Publication Number Publication Date
BRPI0514672A true BRPI0514672A (pt) 2008-06-17

Family

ID=35385423

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514672-0A BRPI0514672A (pt) 2004-08-25 2005-08-25 polipeptìdeos de fusobacterium e métodos de uso

Country Status (9)

Country Link
US (4) US9458204B2 (pt)
EP (1) EP1784417B1 (pt)
AU (1) AU2005280147B2 (pt)
BR (1) BRPI0514672A (pt)
CA (1) CA2578041C (pt)
ES (1) ES2587365T3 (pt)
MX (1) MX2007001886A (pt)
NZ (1) NZ553315A (pt)
WO (1) WO2006026373A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
WO1995021627A1 (en) * 1994-02-09 1995-08-17 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
CA2433561C (en) * 2001-01-03 2014-04-01 Willmar Poultry Company, Inc. Compositions including gram negative siderophore receptor proteins and methods of use
US7641780B2 (en) 2001-05-01 2010-01-05 Calibrant Biosystems, Inc. Two-dimensional microfluidics for protein separations and gene analysis
NZ553315A (en) 2004-08-25 2009-12-24 Epitopix Llc Fusobacterium polypeptides and methods of use
EP2431382A1 (en) 2005-01-21 2012-03-21 Epitopix, LLC Yersinia SPP, polypeptides and methods of use
US20080156080A1 (en) * 2007-01-02 2008-07-03 Calibrant Biosystems, Inc. Methods and systems for multidimensional concentration and separation of biomolecules using capillary isotachophoresis
US20080160629A1 (en) * 2007-01-02 2008-07-03 Calibrant Biosystems, Inc. Methods and systems for off-line multidimensional concentration and separation of biomolecules
US8753643B1 (en) 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use
EP3373964A1 (en) 2015-11-09 2018-09-19 Epitopix, LLC Polypeptides of fusobacterium and methods of use
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455034A (en) * 1992-06-26 1995-10-03 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
WO1995021627A1 (en) * 1994-02-09 1995-08-17 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6241992B1 (en) * 1997-09-08 2001-06-05 University Technologies International, Inc. Bovine footrot treatment and prevention
US6632439B2 (en) * 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US6669940B2 (en) * 2000-04-25 2003-12-30 Kansas University Research Foundation Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
MXPA02010418A (es) * 2000-04-25 2003-04-25 Univ Kansas State Vacuna de leucotoxina de fusobacterium necrophorum recombinante y preparacion de la misma.
CA2433561C (en) * 2001-01-03 2014-04-01 Willmar Poultry Company, Inc. Compositions including gram negative siderophore receptor proteins and methods of use
EP1678316B1 (en) * 2003-09-19 2011-08-17 Epitopix, LLC Campylobacter polypeptides and methods of use
NZ553315A (en) * 2004-08-25 2009-12-24 Epitopix Llc Fusobacterium polypeptides and methods of use

Also Published As

Publication number Publication date
MX2007001886A (es) 2007-04-24
EP1784417B1 (en) 2016-05-18
ES2587365T3 (es) 2016-10-24
US20160376327A1 (en) 2016-12-29
US20160355554A1 (en) 2016-12-08
US10183974B2 (en) 2019-01-22
CA2578041A1 (en) 2006-03-09
CA2578041C (en) 2021-03-16
US9487564B2 (en) 2016-11-08
US20060083753A1 (en) 2006-04-20
WO2006026373A1 (en) 2006-03-09
NZ553315A (en) 2009-12-24
EP1784417A1 (en) 2007-05-16
AU2005280147A1 (en) 2006-03-09
AU2005280147B2 (en) 2011-02-24
US9458204B2 (en) 2016-10-04
US20080199941A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
ECSP099027A (es) Anticuerpos anti-dll4 y métodos que los usan
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
ECSP088543A (es) Anticuerpos anti-ox40l y métodos que los utilizan
UY28342A1 (es) Nuevos compuestos
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
BRPI0606506A2 (pt) polipeptìdeos de yersinia spp. e métodos de uso
CY1110780T1 (el) Τοπικα σκευασματα νεπαφενακης
EA200602129A1 (ru) Новое применение пептидных соединений для лечения дискинезии
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
UY28348A1 (es) Compuestos novedosos
BRPI0713031B8 (pt) composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
UY27894A1 (es) Derivados de cinamida.
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
CR10280A (es) Anticuerpos de la efgl7 y metodos de uso
CL2011001078A1 (es) Compuestos derivados de espirodihidrotetraazabenzoazuleno; procedimiento de preparacion; composicion farmaceutica; y su uso para la prevencion o tratamiento de dismenorrea, disfuncion sexual, hipertension, cirrosis hepatica y esquizofrenia entre otras.
BRPI0607323A2 (pt) composições e uso de polipeptìdeos e kits para a detecção de anticorpo que se liga especificamente a um polipeptìdeo
BRPI0514672A (pt) polipeptìdeos de fusobacterium e métodos de uso
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
PA8577701A1 (es) Polipeptido t20 pegilado
BRPI0609765A8 (pt) mistura de isoalcano, método para a preparação da mesma, composição cosmética ou farmacêutica, e, uso de uma mistura de isoalcano

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2153 DE 10/04/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 11, 8O C/C 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]